Morgan Stanley’s Biohaven BHVN Stock Holding History
Bought
Maintained
Sold
Other funds holding BHVN
SCM
JT
WP
IAM
Morgan Stanley's BHVN Position: Q2 2026 in Review
Morgan Stanley reduced its Biohaven (BHVN) stake by 18% in Q2 2026, selling an estimated $2M and leaving 841,351 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3518.
Morgan Stanley first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $35.5M in Q1 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.
- Morgan Stanley held 841,351 shares of Biohaven worth $12.5M as of Q2 2026.
- Morgan Stanley sold 185,581 Biohaven shares in Q2 2026, an estimated $2M.
- Biohaven made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3518 holding.
- Morgan Stanley first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
- Morgan Stanley's Biohaven position peaked at $35.5M in Q1 2024.
- 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.